- Investing Ideas
- /
- French Pharmaceuticals & Biotech Financially Fit Penny Stocks
French Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
5
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
5 companies
Aelis Farma
Market Cap: €15.0m
A clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France.
AELIS
€1.10
7D
-20.3%
1Y
-75.8%
Cellectis
Market Cap: €215.9m
A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.
ALCLS
€2.99
7D
-2.8%
1Y
52.8%
Valbiotis
Market Cap: €12.6m
Engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France.
ALVAL
€0.79
7D
-0.1%
1Y
-38.8%
ABIONYX Pharma
Market Cap: €126.2m
A biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases.
ABNX
€3.64
7D
-4.2%
1Y
188.4%
genOway Société anonyme
Market Cap: €27.5m
A biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide.
ALGEN
€2.98
7D
4.2%
1Y
-22.6%